Roche invests 7.5 billion Euros each year in research and development in order to help patients through scientific excellence.
Dr. Severin Schwan
Chief Executive Officer Roche Gruppe
The Pharma and Diagnostics divisions both use a broad range of technologies in the search for new tests and more targeted therapies in five core areas: Oncology, virology, inflammatory diseases, neuroscience, and metabolism.
Roche publishes clinical trial results via numerous channels so that health professionals, researchers, patients, and the public are informed of potential new medications that are being developed.